Literature DB >> 20351041

Direct voltage control of endogenous lysophosphatidic acid G-protein-coupled receptors in Xenopus oocytes.

Juan Martinez-Pinna1, Iman S Gurung, Martyn P Mahaut-Smith, Andrés Morales.   

Abstract

Lysophosphatidic acid (LPA) G-protein-coupled receptors (GPCRs) play important roles in a variety of physiological and pathophysiological processes, including cell proliferation, angiogenesis, central nervous system development and carcinogenesis. Whilst many ion channels and transporters are recognized to be controlled by a change in cell membrane potential, little is known about the voltage dependence of other proteins involved in cell signalling. Here, we show that the InsP(3)-mediated Ca(2+) response stimulated by the endogenous LPA GPCR in Xenopus oocytes is potentiated by membrane depolarization. Depolarization was able to repetitively stimulate transient [Ca(2+)](i) increases after the initial agonist-evoked response. In addition, the initial rate and amplitude of the LPA-dependent Ca(2+) response were significantly modulated by the steady holding potential over the physiological range, such that the response to LPA was potentiated at depolarized potentials and inhibited at hyperpolarized potentials. Enhancement of LPA receptor-evoked Ca(2+) mobilization by membrane depolarization was observed over a wide range of agonist concentrations. Importantly, the amplitude of the depolarization-evoked intracellular Ca(2+) increase displayed an inverse relationship with agonist concentration such that the greatest effect of voltage was observed at near-threshold levels of agonist. Voltage-dependent Ca(2+) release was not induced by direct elevation of InsP(3) or by activation of heterotrimeric G-proteins in the absence of agonist, indicating that the LPA GPCR itself represents the primary site of action of membrane voltage. This novel modulation of LPA signalling by membrane potential may have important consequences for control of Ca(2+) signals both in excitable and non-excitable tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351041      PMCID: PMC2887987          DOI: 10.1113/jphysiol.2009.183418

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  48 in total

1.  On the discrepancy between whole-cell and membrane patch mechanosensitivity in Xenopus oocytes.

Authors:  Y Zhang; O P Hamill
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

2.  Properties of the demarcation membrane system in living rat megakaryocytes.

Authors:  Martyn P Mahaut-Smith; David Thomas; Alex B Higham; Juliet A Usher-Smith; Jamila F Hussain; Juan Martinez-Pinna; Jeremy N Skepper; Michael J Mason
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

3.  Two novel Xenopus homologs of mammalian LP(A1)/EDG-2 function as lysophosphatidic acid receptors in Xenopus oocytes and mammalian cells.

Authors:  Y Kimura; A Schmitt; N Fukushima; I Ishii; H Kimura; A R Nebreda; J Chun
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

4.  Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

Authors:  D L Baker; D M Desiderio; D D Miller; B Tolley; G J Tigyi
Journal:  Anal Biochem       Date:  2001-05-15       Impact factor: 3.365

Review 5.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

6.  The M2 muscarinic G-protein-coupled receptor is voltage-sensitive.

Authors:  Yair Ben-Chaim; Oded Tour; Nathan Dascal; Itzchak Parnas; Hanna Parnas
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

7.  A common mechanism underlies vertebrate calcium signaling and Drosophila phototransduction.

Authors:  I Chorna-Ornan; T Joel-Almagor; H C Ben-Ami; S Frechter; B Gillo; Z Selinger; D L Gill; B Minke
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

Review 8.  International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Edward J Goetzl; Timothy Hla; Yasuyuki Igarashi; Kevin R Lynch; Wouter Moolenaar; Susan Pyne; Gabor Tigyi
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 9.  Lysophospholipid receptors.

Authors:  N Fukushima; I Ishii; J J Contos; J A Weiner; J Chun
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

10.  Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells.

Authors:  G Tigyi; R Miledi
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

View more
  5 in total

1.  Voltage regulates adrenergic receptor function.

Authors:  Andreas Rinne; Alexandra Birk; Moritz Bünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

2.  Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.

Authors:  Charles E Norton; Brad R S Broughton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

3.  Membrane Potential Controls the Efficacy of Catecholamine-induced β1-Adrenoceptor Activity.

Authors:  Alexandra Birk; Andreas Rinne; Moritz Bünemann
Journal:  J Biol Chem       Date:  2015-09-25       Impact factor: 5.157

4.  Membrane depolarization is required for pressure-dependent pulmonary arterial tone but not enhanced vasoconstriction to endothelin-1 following chronic hypoxia.

Authors:  Charles E Norton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Pulm Circ       Date:  2020-12-08       Impact factor: 3.017

5.  Voltage modulates the effect of μ-receptor activation in a ligand-dependent manner.

Authors:  Julia G Ruland; Sina B Kirchhofer; Sebastian Klindert; Chris P Bailey; Moritz Bünemann
Journal:  Br J Pharmacol       Date:  2020-05-19       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.